8 employees
Biosortia works on new drugs from deep access to the chemistry of the microbiome for immuno-oncology and immunological therapeutics.
2009
$8M
from 1 investors over 1 rounds
Biosortia, Inc. - Microbiomics raised $8M on January 1, 2016
Investors: Keiretsu Forum / Capital